Moneycontrol
HomeNewsBusinessAlembic Pharma gets USFDA nod for anti-influenza drug
Trending Topics

Alembic Pharma gets USFDA nod for anti-influenza drug

"The company has received approval from the United States Food and Drug Administration (USFDA) for its ANDA for Amantadine Hydrochloride capsules USP 100 mg," Alembic Pharmaceuticals said in a BSE filing.

June 22, 2017 / 11:12 IST
Story continues below Advertisement

Drug firm Alembic Pharmaceuticals has received US health regulator's nod for Amantadine Hydrochloride capsules used to treat symptoms of infection caused by influenza virus.

"The company has received approval from the United States Food and Drug Administration (USFDA) for its ANDA for Amantadine Hydrochloride capsules USP 100 mg," Alembic Pharmaceuticals said in a BSE filing.

Story continues below Advertisement

The approved Abbreviated New Drug Application (ANDA) is equivalent to Symmetrel capsules of Endo Pharmaceuticals.

Amantadine Hydrochloride capsules are used for the "treatment of signs and symptoms of infection caused by various strains of influenza A virus", the company said.